ESC 365 - CYP2C19 genetic variants and coronary atherosclerosis: insights beyond antiplatelet therapy

ESC2025 Premium Access

CYP2C19 genetic variants and coronary atherosclerosis: insights beyond antiplatelet therapy

Session: Antithrombotic therapy in acute coronary syndromes

Topic: Thrombosis, Platelets, and Coagulation

Speaker: Doctor S. Chiusolo (Pisa, IT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Simona Chiusolo

Pisa University Hospital, Pisa (Italy)

0 follower

7 more presentations in this session

Prognostic role of PRECISE-DAPT score in acute coronary syndrome: insight from sigle centre registry

Speaker: Doctor D. Bauer (Prague, CZ)

Anticoagulation for treatment of left ventricular thrombus: an systematic review and meta-analysis

Speaker: Doctor I. Schmal (Lucerne, CH)

Impact of pretreatment with P2Y12 receptor inhibitors on type 4a myocardial infarction and bleeding in patients with non-ST-segment elevation myocardial infarction: a propensity score matching study

Speaker: Doctor N. Vasumini (Bologna, IT)

A shorter duration of dual-antiplatelet therapy for percutaneous coronary intervention following acute coronary syndrome: a meta-analysis of randomized clinical trials

Speaker: Doctor S. Dasari (Bloomington, US)

Effect of P2Y12 pretreatment on angiographic findings and in-hospital mortality in patients with ST-elevation myocardial infarction

Speaker: Doctor N. Vythoulkas-Biotis (Athens, GR)

Access the full session

Antithrombotic therapy in acute coronary syndromes

Speakers: Doctor S. Chiusolo, Doctor D. Bauer, Doctor I. Schmal, Doctor N. Vasumini, Doctor S. Dasari...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources